Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

National Healthcare (NHC) EBITDA Margin (2016 - 2025)

National Healthcare's EBITDA Margin history spans 16 years, with the latest figure at 8.86% for Q4 2025.

  • For Q4 2025, EBITDA Margin fell 35.0% year-over-year to 8.86%; the TTM value through Dec 2025 reached 8.6%, up 116.0%, while the annual FY2025 figure was 8.73%, 155.0% up from the prior year.
  • EBITDA Margin reached 8.86% in Q4 2025 per NHC's latest filing, up from 7.94% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 9.22% in Q4 2024 to a low of 8.24% in Q4 2022.
  • Average EBITDA Margin over 5 years is 5.21%, with a median of 5.36% recorded in 2021.
  • Peak YoY movement for EBITDA Margin: plummeted -1146bps in 2022, then surged 1431bps in 2023.
  • A 5-year view of EBITDA Margin shows it stood at 3.23% in 2021, then crashed by -355bps to 8.24% in 2022, then soared by 174bps to 6.07% in 2023, then surged by 52bps to 9.22% in 2024, then fell by -4bps to 8.86% in 2025.
  • Per Business Quant, the three most recent readings for NHC's EBITDA Margin are 8.86% (Q4 2025), 7.94% (Q3 2025), and 9.09% (Q2 2025).